Clinical trial
Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant
NCT00143845 · University of Michigan Rogel Cancer Center, Other · Completed
Key facts
| NCT number | NCT00143845 |
|---|---|
| Title | Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant |
| Official title | Phase II Trial of Adjuvant Cellular Immunotherapy for High-Risk Hematologic Malignancy After Reduced Intensity Allogeneic Stem Cell Transplantation |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma, Lymphocytic Leukemia, Chronic, Lymphoma, Low-Grade |
| Intervention type | Procedure |
| Interventions | Reduced intensity conditioning, Rapid immunosuppressive taper, Prophylactic donor leukocyte infusions |
| Enrollment | 54 |
| Start date | Apr 1, 2003 |
| Primary completion | Nov 1, 2010 |
| Completion | Feb 1, 2013 |
| First posted | Sep 2, 2005 |
| Last update posted | Mar 8, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: